Latest Hodgkin's lymphoma Stories
SEATTLE, Sept. 11, 2012 /PRNewswire/ -- Cell Therapeutics, Inc. ("CTI") (NASDAQ and MTA: CTIC), a company focused on translating science into novel cancer therapies, today announced the initiation of the commercial launch of Pixuvri® in the European Union ("E.U.") with entry into Sweden, Denmark and Finland in September, to be followed by Austria and Norway in early October 2012 and Germany, United Kingdom and the Netherlands in November 2012. CTI plans to expand availability to...
September spotlights childhood cancer, which remains the leading cause of death by disease of young Americans. At St. Jude Children's Research Hospital, doctors and scientists are working to change that statistic MEMPHIS, Tenn., Sept. 4, 2012 /PRNewswire-USNewswire/ -- As St. Jude Children's Research Hospital celebrates its 50th anniversary and marks September as Childhood Cancer Awareness Month, investigators are focused on the future. Although survival rates for childhood cancer...
The Leukemia & Lymphoma Society Illinois Chapter (LLS) teams up with Fundinco.org to offer a unique fundraising option for their upcoming Light The Night Walk on October 20th and 21st in Chicagoland and Rockford. Chicago, IL (PRWEB) August 29, 2012 Fundinco.org and The Leukemia & Lymphoma Society are teaming up to offer a unique new fundraiser that allows Light The Night Walk teams to raise funds without soliciting for direct donations. Instead, supporters simply shop online and a...
WHITE PLAINS, N.Y., Aug. 30, 2012 /PRNewswire/ -- Remarkable progress has been made in treating patients with blood cancers, with survival rates for many having doubled or tripled, and in some cases quadrupled, since The Leukemia & Lymphoma Society (LLS) was founded in 1949. Yet, more than 1 million North Americans are fighting blood cancers, the third leading cause of cancer death. Each September LLS observes Blood Cancer Awareness Month to shed light on these diseases and...
WHITE PLAINS, N.Y., Aug. 23, 2012 /PRNewswire/ -- The Leukemia & Lymphoma Society is committed to bringing the most current information about blood cancers to all patients and is pleased to announce a unique educational opportunity for Spanish- and Portuguese-speaking patients with non-Hodgkin lymphoma (NHL) or chronic lymphocytic leukemia (CLL) and their families. On Thursday, September 13 from 1:00 to 2:30 PM Eastern Time, Dr. Christopher R. Flowers from the Winship Cancer...
A University of Rochester Medical Center study challenges treatment guidelines for early stage follicular lymphoma, concluding that six different therapies can bring a remission, particularly if the patient is carefully examined and staged at diagnosis. The research underlines the fact that when cancer strikes, modern patients and their oncologists across the United States are taking many diverse treatment paths when there is scant data to support one method over another. This study...
SAN FRANCISCO, Aug. 9, 2012 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society (LLS) is pleased to announce that America's Cup champions Ted Turner and Gary Jobson will attend the seventh annual Leukemia Cup Regatta weekend, October 20-21, 2012. Hosted by The San Francisco Yacht Club (SFYC) in Belvedere, CA, the Leukemia Cup Regatta supports LLS' mission to find a cure for leukemia, lymphoma, Hodgkin's disease and myeloma and improve the quality of life for patients and...
In the news release, Pharmacyclics® Triggers Significant Milestone Payment and Provides Clinical Program Update, issued 01-Aug-2012 by Pharmacyclics, Inc. over PR Newswire, we are advised by the company that the first paragraph, last sentence, should read "calendar 2012" rather than "calendar 2013" as originally issued inadvertently. The complete, corrected release follows: Pharmacyclics® Triggers Significant Milestone Payment and Provides Clinical Program Update SUNNYVALE,...
ATLANTA, Aug. 1, 2012 /PRNewswire/ -- Global Franchise Group, the strategic brand management company, is pleased to announce their partnership with The Leukemia & Lymphoma Society (LLS) for fundraising efforts beginning on August 1st through September 30th. The company has set a goal of raising $200,000 during their partnership period. The Global Franchise Group family of brands includes Great American Cookies®, Marble Slab Creamery®, MaggieMoo's Ice Cream & Treatery®,...
SUNNYVALE, Calif., Aug. 1, 2012 /PRNewswire/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) announced today that the international Phase III randomized, multicenter, open-label clinical trial, RESONATE(TM) (PCYC-1112), of ibrutinib versus ofatumumab for patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) initiated by Pharmacyclics has enrolled its fifth patient. The enrollment of the fifth patient has subsequently triggered a $50 million...
